COVID-19 Booster Study In Immunocompromised Patients Gives Novavax Another Shot On Goal

Manufacturing Issues Have Delayed Filing

 
• By Andrew McConaghie

While delays to manufacturing have frustrated the vaccine’s submission, Novavax is still confident its nanoparticle-based jab will play a significant role in COVID-19.

Novavax
Novavax has seen its regulatory filings delayed by manufacturing supply and quality issues, but finally looks set to gain its first authorizations later this year.

More from Business

More from Scrip